Kissei Pharmaceutical Co., Ltd.

Kissei Pharmaceutical Co., Ltd. - PE Ratioverified

KSPHF

Price:

$25.77

Market Cap:

$161.87B

Kissei Pharmaceutical Co., Ltd. researches, develops, manufactures, and sells pharmaceutical products primarily in Japan. The company offers Calogra tablets, for the treatment of ulcerative colitis; Tabneos capsules for the treatment of microscopic polyangiitis and granulomatous polyangiitis; Minirin Melt OD tablets; Corsuba Intravenous Dialysis Syringe for the treatment of chronic idiopathic thrombocytopenic purpura; Beova tablets for the treatment of overactive bladder treatment; and Darbepoetin Alfa BS injection JCR for the treatment of renal anemia. Its products in pipeline include CG0070, which is in Phase III clinical trial to treat non-muscle-invasive bladder cancer; Linzagolix, which...[Read more]

Industry

Medical - Pharmaceuticals

IPO Date

2017-03-17

Stock Exchange

OTC

Ticker

KSPHF

The PE Ratio as of August 2026 (TTM) for Kissei Pharmaceutical Co., Ltd. (KSPHF) is 11.99

According to Kissei Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 11.99. This represents a change of -12.73% compared to the average of 13.74 of the last 4 quarters.

Kissei Pharmaceutical Co., Ltd. (KSPHF) Historical PE Ratio (quarterly & annually)

How has KSPHF PE Ratio performed in the past?

The mean historical PE Ratio of Kissei Pharmaceutical Co., Ltd. over the last ten years is 18.93. The current 11.99 PE Ratio has changed 6.23% with respect to the historical average. Over the past ten years (40 quarters), KSPHF's PE Ratio was at its highest in in the September 2019 quarter at 220.42. The PE Ratio was at its lowest in in the March 2020 quarter at -44.80.

Quarterly (TTM)
Annual

Average

18.93

Median

14.66

Minimum

9.12

Maximum

46.12

Kissei Pharmaceutical Co., Ltd. (KSPHF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Kissei Pharmaceutical Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 83.55%

Maximum Annual PE Ratio = 46.12

Minimum Annual Increase = -57.85%

Minimum Annual PE Ratio = 9.12

Quarterly (TTM)
Annual
YearPE RatioChange
202614.030.02%
202514.02-0.21%
202414.0521.47%
202311.5726.86%
20229.12-57.85%
202121.63-53.09%
202046.1283.55%
201925.1364.51%
201815.27-16.92%
201718.3818.27%

Kissei Pharmaceutical Co., Ltd. (KSPHF) Average PE Ratio

How has KSPHF PE Ratio performed in the past?

The current PE Ratio of Kissei Pharmaceutical Co., Ltd. (KSPHF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

14.03

5-year avg

12.56

10-year avg

18.93

Kissei Pharmaceutical Co., Ltd. (KSPHF) PE Ratio vs. Peers

How is KSPHF’s PE Ratio compared to its peers?

Kissei Pharmaceutical Co., Ltd.’s PE Ratio is less than Towa Pharmaceutical Co., Ltd. (36.15), less than Sawai Group Holdings Co., Ltd. (17.46), less than SSY Group Limited (15.10), greater than Evotec SE (-3.15), greater than Nippon Shinyaku Co., Ltd. (7.87), less than BioGaia AB (publ) (32.74), greater than Trulieve Cannabis Corp. (-20.10), greater than Cosmo Pharmaceuticals N.V. (-171.08), less than Raffles Medical Group Ltd (24.18), greater than China Traditional Chinese Medicine Holdings Co. Limited (-18.63),

Build a custom stock screener for Kissei Pharmaceutical Co., Ltd. (KSPHF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kissei Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Kissei Pharmaceutical Co., Ltd. (KSPHF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Kissei Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Kissei Pharmaceutical Co., Ltd.'s PE Ratio?

How is the PE Ratio calculated for Kissei Pharmaceutical Co., Ltd. (KSPHF)?

What is the highest PE Ratio for Kissei Pharmaceutical Co., Ltd. (KSPHF)?

What is the 3-year average PE Ratio for Kissei Pharmaceutical Co., Ltd. (KSPHF)?

What is the 5-year average PE Ratio for Kissei Pharmaceutical Co., Ltd. (KSPHF)?

How does the current PE Ratio for Kissei Pharmaceutical Co., Ltd. (KSPHF) compare to its historical average?